JPWO2023157891A5 - - Google Patents

Info

Publication number
JPWO2023157891A5
JPWO2023157891A5 JP2024501414A JP2024501414A JPWO2023157891A5 JP WO2023157891 A5 JPWO2023157891 A5 JP WO2023157891A5 JP 2024501414 A JP2024501414 A JP 2024501414A JP 2024501414 A JP2024501414 A JP 2024501414A JP WO2023157891 A5 JPWO2023157891 A5 JP WO2023157891A5
Authority
JP
Japan
Prior art keywords
zcchc24
composition
expression
drug
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501414A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023157891A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/005320 external-priority patent/WO2023157891A1/ja
Publication of JPWO2023157891A1 publication Critical patent/JPWO2023157891A1/ja
Publication of JPWO2023157891A5 publication Critical patent/JPWO2023157891A5/ja
Pending legal-status Critical Current

Links

JP2024501414A 2022-02-16 2023-02-15 Pending JPWO2023157891A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022021824 2022-02-16
PCT/JP2023/005320 WO2023157891A1 (ja) 2022-02-16 2023-02-15 がん，炎症性疾患，または肥満の治療に用いるための組成物およびその使用

Publications (2)

Publication Number Publication Date
JPWO2023157891A1 JPWO2023157891A1 (https=) 2023-08-24
JPWO2023157891A5 true JPWO2023157891A5 (https=) 2026-02-24

Family

ID=87578349

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501414A Pending JPWO2023157891A1 (https=) 2022-02-16 2023-02-15

Country Status (3)

Country Link
EP (1) EP4480494A4 (https=)
JP (1) JPWO2023157891A1 (https=)
WO (1) WO2023157891A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024172057A1 (https=) * 2023-02-15 2024-08-22

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018002550A2 (en) * 2015-08-10 2018-09-18 Dana-Farber Cancer Institute, Inc. inhibitor resistance mechanism
EP3423048A4 (en) 2016-02-29 2019-10-23 Synta Pharmaceuticals Corp. COMBINATION THERAPY FOR THE TREATMENT OF EGG CANCER
GB201818792D0 (en) 2018-11-19 2019-01-02 Telonostix Ltd Compounds for telomere length-related treatment of cancer

Similar Documents

Publication Publication Date Title
JP5264739B2 (ja) ポリグルタミン伸長関連疾患を治療するための塩素グアナベンズ誘導体の使用
JP2022504182A (ja) （ｒ）－２－（４－イソプロピルフェニル）－ｎ－（１－（５－（２，２，２－トリフルオロエトキシ）ピリジン－２－イル）エチル）アセトアミドを使用した本態性振戦の処置
CN109415731A (zh) 呈递用于特异性敲低白介素17受体mRNA的反义寡核苷酸(ASO)的脂质体球形核酸(SNA)构建体
ES2773834T3 (es) Métodos y composiciones para tratar la depresión usando ciclobenzaprina
JP2023181398A (ja) 認知症および神経変性状態における興奮、精神病および認知機能低下のためのシクロベンザプリン処置
TW202134436A (zh) 用於神經保護之方法及組成物
JP2020533381A (ja) トラジピタントによるアトピー性皮膚炎の改善された治療
CN106414405A (zh) 心脏重塑和其它心脏病状的治疗
JP2021530494A (ja) 胃腸障害の治療における徐放性５−ヒドロキシトリプトファンの使用
KR20150120479A (ko) 니트라이트의 약제학적 제형 및 이의 용도
RU2587053C2 (ru) Комбинированная терапия и способ оценки невосприимчивости к лечению
CN110338139B (zh) 一种痛风动物模型的构建方法及应用
Bartosova et al. Quercetin alleviates diastolic dysfunction and suppresses adverse pro-hypertrophic signaling in diabetic rats
TW200800158A (en) Methods for neuroprotection
JPWO2023157891A5 (https=)
US12377073B2 (en) Treatments for charcot-marie-tooth disease
JP2019517536A (ja) 神経障害性疼痛の治療のための低用量ｆｌｔ３受容体阻害剤
RU2423981C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона
Fu et al. Aged gut microbiota promotes arrhythmia susceptibility via oxidative stress
JP7696006B2 (ja) 化膿性汗腺炎の治療における使用のためのレミブルチニブ
JP7144052B2 (ja) 掻痒性皮膚疾患の予防又は治療薬
Shrestha et al. Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis
CN120514861B (zh) Nedd8抑制剂在制备抗焦虑药物中的应用
US12005050B2 (en) Methods for preventing or treating H. pylori infection
CN100589798C (zh) 用于心室肥厚或心肌纤维化治疗的含有硝酸酯类药物的组合物